शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSESOURCE NATURAL FOODS & HERBAL· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 3 Sept, 2026 · 13:16 IST

New Statutory Auditor appointed; Executive Director takes on CFO role

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.4%Reaction day
₹107.50
prior close
₹107.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-1.0% vs market
Pharmaceuticals peers, median of 172sector+0.3%-0.8% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
+0.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.4+0.6-1.0+0.3-0.8
Next day
-0.5+1.3-1.8+0.2-0.7
2d
-1.4+1.7-3.1+0.9-2.3
3d
-0.9+2.2-3.1+1.1-2.0
4d
+2.1+2.1+0.0+0.6+1.4
5d
+1.3+1.9-0.5+0.8+0.6
1w
+4.2-1.3+5.5-1.1+5.3
15d
+1.3+1.3+0.0+0.8+0.6
1m
+7.0-0.8+7.8-2.2+9.2
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved: (1) M/s. K B Nambiar & Associates as new Statutory Auditors for 5 years (FY26-27 to FY30-31), replacing M/s. Srinaga & Giridharan who completed their 2nd term. (2) Existing Executive Director Mr. Tejagna K. Katpitia additionally designated as CFO and KMP from Sept 3, 2026. (3) Directors Report for FY25-26 approved. (4) 31st AGM on Sept 30, 2026 at 11:30 AM via video conferencing. E-voting Sept 27-29, 2026.

Likely market impact

Routine auditor rotation after completing two terms. CFO shift to an internal Executive Director signals leadership continuity. No material impact on shareholders.